Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer

Open access
Sparano, Joseph A., Wang, Molin, Zhao, Fengmin, Stearns, Vered, Martino, Silvana, Ligibel, Jennifer A., Perez, Edith A., Saphner, Tom, Wolff, Antonio C., Sledge, George W., Wood, William C., Fetting, John, Davidson, Nancy E.·2012·Cancer

Abstract

BACKGROUND: Obesity has been associated with inferior outcomes in operable breast cancer, but the relation between body mass index (BMI) and outcomes by breast cancer subtype has not been previously evaluated. METHODS: The authors evaluated the relation between BMI and outcomes in 3 adjuvant trials coordinated by the Eastern Cooperative Oncology Group that included chemotherapy regimens with doxorubicin and cyclophosphamide, including E1199, E5188, and E3189. Results are expressed as hazard ratios (HRs) from Cox proportional hazards models (HR >1 indicates a worse outcome). All P values are 2‐sided. RESULTS: When evaluated as a continuous variable in trial E1199, increasing BMI within the obese (BMI, ≥30 kg/m 2) and overweight (BMI, 25‐29.9 kg/m 2) ranges was associated with inferior outcomes in hormone receptor‐positive, human epidermal growth receptor 2 (HER‐2)/neu‐negative disease for disease‐free survival (DFS; P = .0006) and overall survival (OS; P = .0007), but not in HER‐2/neu–overexpressing or triple‐negative disease. When evaluated as a categorical variable, obesity was associated with inferior DFS (HR, 1.24; 95% confidence interval [CI], 1.06‐1.46; P = .0008) and OS (HR, 1.37; 95% CI, 1.13‐1.67; P = .002) in hormone receptor‐positive disease, but not other subtypes. In a model including obesity, disease subtype, and their interaction, the interaction term was significant for OS (P = .02) and showed a strong trend for DFS (P = .07). Similar results were found in 2 other trials (E5188, E3189). CONCLUSIONS: In a clinical trial population that excluded patients with significant comorbidities, obesity was associated with inferior outcomes specifically in patients with hormone receptor‐positive operable breast cancer treated with standard chemohormonal therapy. Cancer 2012. © 2012 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.27527

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 207

Metadata

Authors
Sparano, J. A., Wang, M., Zhao, F., Stearns, V., Martino, S., Ligibel, J. A., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., Fetting, J., & Davidson, N. E.
Venue
Cancer
Publisher
Wiley
Published
2012-08-27
Volume
118
Issue
23
Pages
5937-5946
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2160786885
Cited by
207
References
6
FWCI
9.09
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer. https://app.cochat.ai/papers/10.1002/cncr.27527
The paper
Sparano, J. A., Wang, M., Zhao, F., Stearns, V., Martino, S., Ligibel, J. A., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., Fetting, J., & Davidson, N. E. (2012). Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer. Cancer. https://doi.org/10.1002/cncr.27527

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.